SPRB
SPRB
NASDAQ · Biotechnology

Spruce Biosciences Inc

$56.50
-0.07 (-0.12%)
As of May 16, 2:15 AM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target -20.7% upside
Low Target $31.89
Average Target $44.79
High Target $48.55
Current Price $56.50
Current
$56.50
Target
$44.79
$31.89 $44.79 avg $48.55
Scenario Analysis
Bear Case
$31.89
-43.6%
Low target
Base Case
$44.79
-20.7%
Avg target
Bull Case
$48.55
+-14.1%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$240.00
-76.5% from high
52-Week Low
$4.35
+1,198.9% from low
Target vs 52W High
$44.79
-81.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%